HKSH News

T-cell Engaging Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: A Practical Masterclass

Date:  Aug 3, 2017 (Thu)

Venue:  Hyatt Regency Hong Kong, TST

 

Speakers:

Prof. David Ritchie

Consultant Haematologist and Head of the BMT Service at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre

 

Peter Haywood

Adolescent and Young Adult / Acute Leukaemia Clinical Nurse Consultant, Haematology Department, Royal Melbourne Hospital

 

Agenda:

 

7:00 – 7:15 pm

Registration and Opening

Chairman

7:15 – 8:00 pm

The evolving role of T-cell engaging immunotherapies in ALL

Prof. David Ritchie

8:00 – 8:30 pm

Practical considerations for administration of blinatumomab in patients with relapsed/refractory B-precursor ALL

Peter Haywood

8:30 – 8:45 pm

Q&A

 

8:45 – 10:00 pm

Dinner

 

 T-cell Engaging Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: A Practical Masterclass